Clinical trial
Tolvaptan Oral Administration Phase I Clinical Trial
NCT07166796 is registered in ClinicalTrials.gov with Otsuka Beijing Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolvaptan Oral Administration Phase I Clinical Trial
- Lead sponsor
- Otsuka Beijing Research Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 1, 2006
- Completion date
- January 31, 2007
- Enrollment
- 64 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
health subjects